⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27483043 | 0.97 | — | — | |
| SCHEMBL6381802 | 0.83 | — | — | |
| SCHEMBL105311 | 0.81 | — | — | |
| SCHEMBL5100807 | 0.79 | — | — | |
| SCHEMBL6380771 | 0.79 | CYP4F2 (0.31) | — | |
| SCHEMBL237181 | 0.78 | MAPK1 (0.40) | — | |
| SCHEMBL6651865 | 0.77 | — | — | |
| SCHEMBL1405725 | 0.77 | — | — | |
| SCHEMBL6654154 | 0.77 | — | — | |
| SCHEMBL6656859 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1675 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113874375-A | Cyclic amide compounds and methods thereof for the treatment of rabies | 株式会社大分大学先端医学研究所 | 2021-12-31 | — | — | CN | claimed |
| US-11077434-B2 | Method of preparing metallocene catalyst for polyolefin preparation | LG CHEM, LTD. | 2021-08-03 | — | — | US | claimed |
| WO-2020246503-A1 | CYCLIC AMIDE COMPOUNDS FOR RABIES TREATMENT AND METHOD THEREOF | 株式会社大分大学先端医学研究所 | 2020-12-10 | — | — | WO | claimed |
| CN-108290973-B | Method for preparing metallocene catalyst for preparing polyolefin | LG化学株式会社 | 2020-11-10 | — | — | CN | claimed |
| US-20190224661-A1 | METHOD OF PREPARING METALLOCENE CATALYST FOR POLYOLEFIN PREPARATION | LG CHEM, LTD. (KR) | 2019-07-25 | — | — | US | claimed |
| EP-3357938-A2 | METHOD FOR PREPARING METALLOCENE CATALYST FOR PREPARING POLYOLEFIN | LG Chem, Ltd. (KR) | 2018-08-08 | — | — | EP | claimed |
| CN-108290973-A | It is used to prepare the preparation method of the metallocene catalyst of polyolefin | LG化学株式会社 | 2018-07-17 | — | — | CN | claimed |
| CN-106459794-B | vehicle fuel additive composition and use thereof | 高化学技术株式会社 | 2018-04-03 | — | — | CN | claimed |
| CN-106459794-A | Vehicle fuel additive composition and use thereof | 高化学株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-101801949-B | Sulfonamides as TRPM8 modulators | JANSSEN PHARMACEUTICA NV | 2014-09-24 | — | — | CN | claimed |
| WO-2008130314-A1 | XANTHINE COMPOUNDS HAVING A POSITIVE ALLOSTERIC GABAB RECEPTOR MODULATOR EFFECT | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | claimed |
| WO-2007069986-A1 | NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS | ASTRAZENECA AB (SE) | 2007-06-21 | — | — | WO | claimed |
| CN-1649863-A | 4- (imidazol-5-yl) -2- (4-sulfoanilino) pyrimidine derivatives having CDK inhibitory activity | ASTRAZENECA AB (SE) | 2005-08-03 | — | — | CN | claimed |
| US-20050131000-A1 | Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity | ASTRAZENECA AB (SE) | 2005-06-16 | — | — | US | claimed |
| EP-1487823-A1 | DERIVATIVES OF 4-(IMIDAZOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2004-12-22 | — | — | EP | claimed |
| WO-2003076436-A1 | DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2003-09-18 | — | — | WO | claimed |
| CN-1415619-A | Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage | INST OF TOXICANT AND MEDICAMEN (CN) | 2003-05-07 | — | — | CN | claimed |
| CN-1415617-A | Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science | INST OF TOXICANT AND MEDICAMEN (CN) | 2003-05-07 | — | — | CN | claimed |
| CN-1415618-A | Compound possessing function for preventing and curing thrombus disease, its pharmacy compsn. and usage in medication | INST OF TOXICANT AND MEDICAMEN (CN) | 2003-05-07 | — | — | CN | claimed |
| WO-1996040692-A1 | ORGANOLITHIUM PROCESS | FMC CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |